Neuronetics consolidates top finance roles under Naor

Neuronetics, Inc. announced a leadership transition in its finance function.

Rhea-AI Filing Summary

Neuronetics, Inc. announced a leadership transition in its finance function. On August 11, 2026, Francis X. Brown III’s service as the company’s interim principal financial and accounting officer ended; the company states this change is not due to any dispute or disagreement with him regarding operations, policies, or practices, and he will continue as a consultant. The Board had previously appointed Nir Naor as Executive Vice President, Chief Financial Officer, and Treasurer effective July 23, 2026, and on August 12, 2026, expanded his responsibilities by designating him as principal financial and accounting officer and Corporate Secretary. Neuronetics notes that Mr. Naor received no additional compensation in connection with these expanded roles, discloses that there are no family relationships or arrangements underlying his selection, and states there are no related party transactions requiring disclosure under Regulation S-K Item 404(a).

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Terms

principal financial and accounting officer, Corporate Secretary, related party transactions, Item 404(a) of Regulation S-K

4 terms

principal financial and accounting officer financial

"appointed Mr. Naor to serve as the Company’s principal financial and accounting officer"

Corporate Secretary regulatory

"Mr. Naor’s title is now Executive Vice President, Chief Financial Officer, Corporate Secretary"

A corporate secretary is a person in a company who helps organize meetings, keeps important records, and makes sure the company follows legal rules. They act like a bridge between the company's leaders and its shareholders, making sure everything runs smoothly and by the book. Their role is important because it helps the company stay organized and legally compliant.

related party transactions financial

"There are no related party transactions between Mr. Naor and the Company"

Transactions between a company and people or entities that have close ties to it—such as executives, board members, major shareholders, family members, or related companies—where the parties are not independent. These deals matter to investors because they can create conflicts of interest or hide favorable terms that distort a company’s true profits and risks; think of it like a business buying or selling to a family member instead of using the open market, which can lead to biased prices or undisclosed obligations.

Item 404(a) of Regulation S-K regulatory

"that would require disclosure under Item 404(a) of Regulation S-K"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive leadership change did Neuronetics, Inc. (STIM) report on August 11, 2026?

Neuronetics reported that on August 11, 2026, interim principal financial and accounting officer Francis X. Brown III ended his service in that role. He will continue to serve the company as a consultant, and the change was not due to any dispute or disagreement.

What is Nir Naor’s new role at Neuronetics, Inc. (STIM)?

Nir Naor now serves as Neuronetics’ Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer and has been appointed as the company’s principal financial and accounting officer. His responsibilities were expanded by Board action on August 12, 2026.

Did Neuronetics, Inc. (STIM) state any disagreements with Francis X. Brown III related to his transition?

No. Neuronetics stated that the end of Francis X. Brown III’s appointment as interim principal financial and accounting officer was not the result of any dispute or disagreement regarding the company’s operations, policies, or practices, and he will remain as a consultant.

Did Nir Naor receive additional compensation for his expanded duties at Neuronetics, Inc. (STIM)?

No. Neuronetics stated that Nir Naor did not receive any new compensation in connection with his appointment as principal financial and accounting officer, his appointment as Corporate Secretary, or the modification of his title.

Are there any related party transactions involving Nir Naor at Neuronetics, Inc. (STIM)?

The company stated there are no related party transactions between Nir Naor and Neuronetics that would require disclosure under Item 404(a) of Regulation S-K. It also noted no family relationships with directors or other executive officers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:10 PM Accepted by SEC EDGAR 08/17/2026 - 04:10 PM Learn about SEC filing dates

false 0001227636 0001227636 2026-08-11 2026-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 11, 2026

NEURONETICS, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38546		33-1051425
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3222 Phoenixville Pike, Malvern, PA		19355
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (877) 600-7555

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock ($0.01 par value)		STIM		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On August 11, 2026, in connection with Mr. Naor’s appointment (as described below), Francis X. Brown III’s appointment as Neuronetics, Inc.’s (the “Company”) interim principal financial and accounting officer ended. Such event is not the result of any dispute or disagreement between Mr. Brown and the Company, the Company’s management, or the Company’s Board on any matter relating to the Company’s operations, policies, or practices. Mr. Brown will continue to serve as a consultant.

(c) As previously disclosed, the Board of Directors of the Company (the “Board”) appointed Nir Naor as the Company’s Executive Vice President, Chief Financial Officer, and Treasurer with an effective date of July 23, 2026. On August 12, 2026, the Board appointed Mr. Naor to serve as the Company’s principal financial and accounting officer. Mr. Naor’s title is now Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer. Mr. Naor did not receive any new compensation in connection with his appointment as the principal financial and accounting officer, his appointment as the corporate secretary, or the modification of his title. Mr. Naor’s biographical information can be found in the Company’s Current Report on Form 8-K filed on July 20, 2026.

There is no arrangement or understanding between Mr. Naor and any other person pursuant to which Mr. Naor was selected as an officer of the Company, and there is no family relationship between Mr. Naor and any of the Company’s directors or other executive officers. There are no related party transactions between Mr. Naor and the Company that would require disclosure under Item 404(a) of Regulation S-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 17, 2026				NEURONETICS, INC.
				By:		/s/ Nir Naor
						Nir Naor
						Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.1 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 16.8 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 10.6 KB